BETAMOX 150 MG/ML SUSPENSION FOR INJECTION.

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

AMOXICILLIN

Διαθέσιμο από:

Norbrook Laboratories Limited

Φαρμακολογική κατηγορία (ATC):

QJ01CA04

INN (Διεθνής Όνομα):

AMOXICILLIN

Δοσολογία:

150 Mg/Ml

Φαρμακοτεχνική μορφή:

Suspension for Injection

Τρόπος διάθεσης:

POM

Θεραπευτική ομάδα:

Bovine, Ovine, Porcine

Θεραπευτική περιοχή:

Amoxicillin

Θεραπευτικές ενδείξεις:

Antibacterial

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

1987-10-01

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Betamox 150 mg/ml Suspension for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
150 mg amoxicillin (as Amoxicillin Trihydrate), and 0.08 mg butylated
hydroxytoluene (E321) and 0.08 mg butylated
hydroxyanisole (E320) as antioxidants.
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection.
An off-white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, Sheep, Pigs, Dogs, Cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of infections caused by a wide range of
Gram-positive and Gram-negative pathogenic bacteria including:
_Bacillus anthracis_
_Haemophilus_ spp.
_Bacillus cereus_
_Pasteurella_ spp.
_Bordetella bronchiseptica_
_Proteus mirabilis_
_Clostridium spp._
_Salmonella_ spp.
_Corynebacterium spp_.
non-penicillinase producing
_Erysipelothrix rhusiopathiae_
Staphylococci
_Escherichia coli_
non-penicillinase producing
_Fusiformis_ spp.
Streptococci
4.3 CONTRAINDICATIONS
Not for intravenous or intrathecal use
Do not use in rabbits, hamsters, gerbils and guinea pigs
Do not use in sheep producing milk for human consumption.
Do not use in known cases of hypersensitivity to
amoxicillin/penicillin.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_9_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_1_
_2_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS FOR EA